Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL245689 | 0.97 | — | — | |
| Methylamine SCHEMBL27328071 | 0.95 | GRIN2D (0.48) | — | |
| Ammonia Solution, Strong SCHEMBL28846277 | 0.95 | — | — | |
| Bromide SCHEMBL14862173 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL5477741 | 0.91 | SPHK1 (0.54) | — | |
| Hydrochloric Acid SCHEMBL4168689 | 0.91 | SPHK1 (0.54) | — | |
| Dodine SCHEMBL425946 | 0.91 | SPHK1 (0.54) | — | |
| Hydrochloric Acid SCHEMBL5319578 | 0.91 | SPHK1 (0.54) | — | |
| Hydrochloric Acid SCHEMBL14862037 | 0.91 | SPHK1 (0.54) | — | |
| Hydrochloric Acid SCHEMBL1738411 | 0.91 | SPHK1 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105693972-B | The preparation method of antibacterial modified polyurethane flexible foam | 华东理工大学 | 2019-06-14 | — | — | CN | claimed |
| CN-116723714-A | Modified perovskite film, efficient stable perovskite solar cell and preparation method thereof | 华侨大学 | 2023-09-08 | — | — | CN | disclosed |
| CN-116723714-A | Modified perovskite film, efficient stable perovskite solar cell and preparation method thereof | 华侨大学 | 2023-09-08 | — | — | CN | disclosed |
| CN-111154370-B | Antibacterial acrylate coating and preparation method and application thereof | 华东理工大学 | 2021-06-08 | — | — | CN | disclosed |
| WO-2020218835-A1 | NOVEL POLYIMIDE-TYPE POLYMER AND PREPARATION METHOD THEREFOR | 서울대학교 산학협력단 | 2020-10-29 | — | — | WO | disclosed |
| CN-111154370-A | Antibacterial acrylate coating and preparation method and application thereof | 华东理工大学 | 2020-05-15 | — | — | CN | disclosed |
| CN-105693972-B | The preparation method of antibacterial modified polyurethane flexible foam | 华东理工大学 | 2019-06-14 | — | — | CN | disclosed |
| CN-107690281-A | Cystic fibrosis transmembrane transduction modulator modulators | 弗特克斯药品有限公司 | 2018-02-13 | — | — | CN | disclosed |
| CN-104822670-A | 5-phenoxy-3h-pyrimidin-4-one derivatives and their use as HIV reverse transcriptase inhibitors | MERCK SHARP & DOHME | 2015-08-05 | — | — | CN | disclosed |
| EP-1983051-B1 | Isolation and purification of nucleic acid molecules with solid phase | ROCHE DIAGNOSTICS GMBH (DE) | 2014-11-26 | — | — | EP | disclosed |
| EP-2035401-B1 | ARYL- AND HETEROARYL-ETHYL-ACYLGUANIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS | SANOFI AVENTIS (FR) | 2011-02-23 | — | — | EP | disclosed |
| US-20090203696-A1 | Aryl- and Heteroaryl-Ethyl-Acylguanidine Derivatives, Their Preparation and Their Application in Therapeutics | SANOFI-AVENTIS (FR) | 2009-08-13 | — | — | US | disclosed |
| EP-2035401-A2 | ARYL- AND HETEROARYL-ETHYL-ACYLGUANIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS | Sanofi-Aventis (FR) | 2009-03-18 | — | — | EP | disclosed |
| US-20080319182-A1 | ISOLATION AND PURIFICATION OF NUCLEIC ACIDS WITH A SOLID PHASE | ROCHE DIAGNOSTICS GMBH (DE) | 2008-12-25 | — | — | US | disclosed |
| EP-1983051-A2 | Isolation and purification of nucleic acid molecules with solid phase | Roche Diagnostics GmbH (DE) | 2008-10-22 | — | — | EP | disclosed |
| EP-1449519-B1 | Liquid composition containing a guanidine amide group derivative and/or a salt thereof | AJINOMOTO KK (JP) | 2008-07-09 | — | — | EP | disclosed |
| EP-1873200-A1 | An improved process for making an external plasticization of aliphatic polyamides and plasticizers useful for said plasticization | Arkema France (FR) | 2008-01-02 | — | — | EP | disclosed |
| WO-2007144769-A2 | ARYL- AND HETEROARYL-ETHYL-ACYLGUANIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS | SANOFI-AVENTIS (FR) | 2007-12-21 | — | — | WO | disclosed |
| US-20040176464-A1 | Liquid composition with improved storage stability, which contains an amide group-containing guanidine derivative or/and a salt thereof | AJINOMOTO CO., INC. (JP) | 2004-09-09 | — | — | US | disclosed |
| EP-1449519-A1 | Liquid composition containing a guanidine amide group derivative and/or a salt thereof | Ajinomoto Co., Inc. (JP) | 2004-08-25 | — | — | EP | disclosed |